(3R,4S)-3,4-Dihydroxypiperidin-2-One

Details

Top
Internal ID 3c520647-ad1c-4e28-9381-39ff8a8c0f0e
Taxonomy Organoheterocyclic compounds > Piperidines > Piperidinones
IUPAC Name (3R,4S)-3,4-dihydroxypiperidin-2-one
SMILES (Canonical) C1CNC(=O)C(C1O)O
SMILES (Isomeric) C1CNC(=O)[C@@H]([C@H]1O)O
InChI InChI=1S/C5H9NO3/c7-3-1-2-6-5(9)4(3)8/h3-4,7-8H,1-2H2,(H,6,9)/t3-,4+/m0/s1
InChI Key HVIVBJVEAQHMTG-IUYQGCFVSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C5H9NO3
Molecular Weight 131.13 g/mol
Exact Mass 131.058243149 g/mol
Topological Polar Surface Area (TPSA) 69.60 Ų
XlogP -1.60
Atomic LogP (AlogP) -1.77
H-Bond Acceptor 3
H-Bond Donor 3
Rotatable Bonds 0

Synonyms

Top
(3R,4S)-3,4-dihydroxypiperidin-2-one

2D Structure

Top
2D Structure of (3R,4S)-3,4-Dihydroxypiperidin-2-One

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7384 73.84%
Caco-2 - 0.9379 93.79%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability + 0.9143 91.43%
Subcellular localzation Mitochondria 0.7646 76.46%
OATP2B1 inhibitior - 0.8443 84.43%
OATP1B1 inhibitior + 0.9723 97.23%
OATP1B3 inhibitior + 0.9514 95.14%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9735 97.35%
P-glycoprotein inhibitior - 0.9848 98.48%
P-glycoprotein substrate - 0.9380 93.80%
CYP3A4 substrate - 0.6897 68.97%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8156 81.56%
CYP3A4 inhibition - 0.9957 99.57%
CYP2C9 inhibition - 0.9685 96.85%
CYP2C19 inhibition - 0.9708 97.08%
CYP2D6 inhibition - 0.9608 96.08%
CYP1A2 inhibition - 0.9356 93.56%
CYP2C8 inhibition - 0.9936 99.36%
CYP inhibitory promiscuity - 0.9924 99.24%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9500 95.00%
Carcinogenicity (trinary) Non-required 0.7388 73.88%
Eye corrosion - 0.9801 98.01%
Eye irritation + 0.7331 73.31%
Skin irritation - 0.7487 74.87%
Skin corrosion - 0.9313 93.13%
Ames mutagenesis - 0.7000 70.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7048 70.48%
Micronuclear + 0.5132 51.32%
Hepatotoxicity + 0.7462 74.62%
skin sensitisation - 0.8808 88.08%
Respiratory toxicity - 0.6778 67.78%
Reproductive toxicity + 0.7778 77.78%
Mitochondrial toxicity + 0.7500 75.00%
Nephrotoxicity + 0.5113 51.13%
Acute Oral Toxicity (c) III 0.6742 67.42%
Estrogen receptor binding - 0.8789 87.89%
Androgen receptor binding - 0.7733 77.33%
Thyroid receptor binding - 0.7647 76.47%
Glucocorticoid receptor binding - 0.7943 79.43%
Aromatase binding - 0.8606 86.06%
PPAR gamma - 0.8273 82.73%
Honey bee toxicity - 0.9158 91.58%
Biodegradation + 0.5250 52.50%
Crustacea aquatic toxicity - 0.6100 61.00%
Fish aquatic toxicity - 0.9976 99.76%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3137262 O60341 LSD1/CoREST complex 92.35% 97.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 88.22% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 87.92% 96.09%
CHEMBL2581 P07339 Cathepsin D 86.12% 98.95%
CHEMBL4040 P28482 MAP kinase ERK2 82.03% 83.82%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 80.64% 93.03%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Piper longum

Cross-Links

Top
PubChem 71720812
NPASS NPC224624